MarketInOut Stock Screener Log In | Sign Up
 

Champions Oncology Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Champions Oncology Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization66.25 mln
Float6.09 mln
Earnings Date12/15/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-1.48
Manipulation likely

Relative Strength

45 / 100
Slightly lagging

Debt / Equity

2.82
Very high leverage

Pre-Tax Margin

-1%
Barely loss-making

ROE

-27.89
Deeply negative

Business Description

Champions Oncology is a US-based research company that helps pharmaceutical and biotechnology firms develop cancer drugs by implanting human tumors into specially bred mice, allowing scientists to study how those tumors respond to treatment. The company also offers Lumin Bioinformatics, a software tool that pulls together data from research and clinical studies to support drug development decisions. Founded in 1985 and based in Hackensack, New Jersey, Champions Oncology reaches its clients through online channels and a dedicated sales team.

Key Fundamentals

EPS-0.07
ROE-27.89
RPS4.38
ROIC-4.20
ROA-3.69
EBITDA, mln0.40
EV / EBITDA192
EV / EBIT-85.63
Revenue, mln60.66
EV / Revenue1.26

Quote Details

Last 4.72
Change -0.04 (-0.84%)
Open 4.65
Volume 3,676
Turnover 17,351
Average Volume 9,318.38

Financial Ratios

Pre-Tax Profit Margin-1
Leverage Ratio8.55
Current Ratio1.03
Price / Book15.56
Price / Tangible Book16.60
Debt / Equity2.82
Price / Sales1.15

Financial Strength

Altman Z-Score-0.29
Piotroski F-Score 2 / 9
Beneish M-Score-1.48
Short Ratio4.95
Short % of Float1.04

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.43% 64 / 100   
1 Month -4.65% 41 / 100   
2 Months -22.62% 21 / 100   
6 Months -19.59% 26 / 100   
1 Year -28.92% 26 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog